Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

180.09 -5.61 (-3.02%)
Streaming Delayed Price Updated: 9:55 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Acquires Explora BioLabs
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Wind Contract with Repsol for European Operations
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Expands Strategic Partnership With SAMDI Tech
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Fourth-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Valo Health Announce Strategic Partnership to Provide Clients with Access to AI-Enabled Drug Discovery Solutions
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Chief Financial Officer Retirement and Transition Plan
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Participate in Upcoming Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Promotes Birgit Girshick to Chief Operating Officer
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Third-Quarter 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Plans to Increase CRADL Capacity in Cambridge
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and ATEM Structural Discovery Announce Strategic Partnership to Provide Clients with Cryo-EM Capabilities
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Third-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Two Divestitures
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Launches First Annual Healthcare Collaboration Report
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Participate in September Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Second-Quarter 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Second-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Completes Acquisition of Vigene Biosciences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Long-Term Solar Contract for North American Operations
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Participate in June Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Host Virtual Investor Day
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Acquire Vigene Biosciences to Enhance Gene Therapy Capabilities
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces First-Quarter 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules First-Quarter 2021 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.